Dimensional Fund Advisors’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-22,730
Closed -$180K 3377
2024
Q2
$180K Sell
22,730
-22,804
-50% -$217K ﹤0.01% 3181
2024
Q1
$730K Sell
45,534
-50,243
-52% -$813K ﹤0.01% 2976
2023
Q4
$1.31M Sell
95,777
-19,275
-17% -$221K ﹤0.01% 2878
2023
Q3
$1.68M Sell
115,052
-36,488
-24% -$617K ﹤0.01% 2825
2023
Q2
$2.58M Buy
151,540
+30,546
+25% +$448K ﹤0.01% 2714
2023
Q1
$1.69M Buy
120,994
+36,979
+44% +$393K ﹤0.01% 2779
2022
Q4
$555 Buy
84,015
+34,778
+71% +$208K ﹤0.01% 3021
2022
Q3
$260K Buy
+49,237
New +$304K ﹤0.01% 3191

Other funds holding RCEL

Dimensional Fund Advisors's RCEL Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of Avita Medical (RCEL) in Q3 2024, closing a stake of 22,730 shares — an estimated $180K sold.

Dimensional Fund Advisors first reported a position in RCEL in Q3 2022 and held it in 8 quarters. The position peaked at $2.58M in Q2 2023. 67 funds tracked by Wall St. Rank hold RCEL as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining Avita Medical position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 22,730 Avita Medical shares in Q3 2024, an estimated $180K.
  • Dimensional Fund Advisors first reported a position in Avita Medical in Q3 2022 and held it in 8 quarters.
  • Dimensional Fund Advisors's Avita Medical position peaked at $2.58M in Q2 2023.
  • 67 funds tracked by Wall St. Rank held Avita Medical as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.